Anteris Technologies Global Corp. — AGM Information 2008

Nov 11, 2008

==> picture [596 x 64] intentionally omitted <==

Innovative BioMedical Devices

Level 11, 225 St Georges Terrace bioMD Limited ABN 35 088 221 078 Perth, Western Australia 6000 PO Box 7209, Cloisters Square Western Australia 6850

Telephone (08) 9262 6777 Facsimile (08) 9322 3433

www.biomd.com.au

ANNOUNCEMENT TO THE AUSTRALIAN STOCK EXCHANGE

1 of 23 pages

12 November 2008

Company Announcements Office Australian Stock Exchange Limited 10[th] Floor, 20 Bond Street SYDNEY NSW 2000

Annual General Meeting Presentation

The Directors of bioMD Limited (the "Company") are pleased to announce the Presentation for the 5[th] Annual General Meeting of the company to be held today.

Yours faithfully

==> picture [79 x 59] intentionally omitted <==

Caroline Bentley Company Secretary

==> picture [596 x 42] intentionally omitted <==

Annual General Meeting

12 November 2008

==> picture [720 x 78] intentionally omitted <==

AGENDA

WELCOME

Mr Robert Scott, Chairman of the Board

CHAIRMAN’S ADDRESS

RESOLUTIONS

• 1) Adopt the Remuneration Report for the Year Ended 30 June 2008

• 2) Re-election of Director – Mr Robert Towner

MANAGING DIRECTOR’S ADDRESS Mr Michael Bennett

==> picture [720 x 78] intentionally omitted <==

Company Highlights Commenced Phase II Human Clinical Trial of CardioCel Signing of Services Agreement with Cell & Tissue Therapies WA, Royal Perth Hospital, for the provision of laboratory services to produce CardioCel patches Inclusion of CardioCel on Australian Register of Therapeutic

==> picture [720 x 78] intentionally omitted <==

What is tissue engineering?

“ An interdisciplinary field that applies the principles of engineering and life sciences toward the development of biological substitutes that restore, maintain, or improve tissue function or a whole organ.”

Source: Langer and Vacanti

==> picture [720 x 78] intentionally omitted <==

ADAPT TISSUE ENGINEERING PROCESS (TEP)

==> picture [20 x 18] intentionally omitted <==

==> picture [20 x 18] intentionally omitted <==

==> picture [20 x 18] intentionally omitted <==

==> picture [20 x 19] intentionally omitted <==

Site specific, controlled tissue remodelling Stem cell transdifferentiation Enhanced crosslinking within the collagen structure Optimal strength and reduced inflammatory response

==> picture [20 x 19] intentionally omitted <==

==> picture [720 x 78] intentionally omitted <==

What is our ADAPT market?

==> picture [24 x 22] intentionally omitted <==

==> picture [24 x 21] intentionally omitted <==

==> picture [24 x 21] intentionally omitted <==

==> picture [24 x 21] intentionally omitted <==

Cardiovascular patches Heart valves Abdominal patches Orthopaedic soft tissue implants

==> picture [720 x 78] intentionally omitted <==

Cardiovascular patches

==> picture [720 x 78] intentionally omitted <==

==> picture [20 x 19] intentionally omitted <==

Cardiovascular patches are commonly used to seal openings in blood vessels and the heart.

==> picture [20 x 18] intentionally omitted <==

==> picture [20 x 18] intentionally omitted <==

The term "cardiovascular patch" is intended to encompass any such material, regardless of shape, which is applied over a cut, tear, or other opening in a blood vessel or similar organ.

The patches reconstruct the opening, preventing leakage which results in a

==> picture [215 x 241] intentionally omitted <==

==> picture [720 x 78] intentionally omitted <==

==> picture [19 x 19] intentionally omitted <==

Phase II Human Clinical Trial underway in South Africa 14 patients implanted with CardioCel bovine pericardial patches treated with ADAPT TEP

==> picture [303 x 215] intentionally omitted <==

==> picture [20 x 18] intentionally omitted <==

Collaboration into ADAPT TEP treated human pericardium

==> picture [720 x 78] intentionally omitted <==

Heart valves

==> picture [336 x 39] intentionally omitted <==

==> picture [720 x 78] intentionally omitted <==

==> picture [456 x 318] intentionally omitted <==

Open heart surgery is the traditional method for heart valve replacement

==> picture [720 x 78] intentionally omitted <==

==> picture [22 x 20] intentionally omitted <==

2 types of artificial heart valve:

==> picture [288 x 19] intentionally omitted <==

----- Start of picture text -----

mechanical tissue
----- End of picture text -----

==> picture [22 x 20] intentionally omitted <==

==> picture [22 x 19] intentionally omitted <==

Tissue valves usually made from animal tissues, either animal heart valve tissue or animal pericardial tissue Tissue must be treated to prevent rejection and calcification

==> picture [720 x 78] intentionally omitted <==

==> picture [24 x 21] intentionally omitted <==

The Future… Percutaneous Heart Valve Replacement Percutaneous valve replacement - the implantation of valves using a catheter without open heart surgery

==> picture [24 x 21] intentionally omitted <==

==> picture [24 x 22] intentionally omitted <==

Alternative to open heart surgery – minimally invasive surgery Transfemoral / transapical placement

==> picture [720 x 78] intentionally omitted <==

==> picture [24 x 21] intentionally omitted <==

Research collaboration in South Africa to develop a kangaroo tissue percutaneous heart valve

==> picture [234 x 175] intentionally omitted <==

----- Start of picture text -----

(.avi)
----- End of picture text -----

==> picture [24 x 22] intentionally omitted <==

Research collaboration in Australia to develop a

==> picture [720 x 78] intentionally omitted <==

Abdominal patches

==> picture [720 x 78] intentionally omitted <==

==> picture [24 x 22] intentionally omitted <==

==> picture [24 x 21] intentionally omitted <==

==> picture [24 x 21] intentionally omitted <==

==> picture [24 x 22] intentionally omitted <==

==> picture [24 x 21] intentionally omitted <==

Biologic material, ideal for soft tissue repairs Enables normal healing, including remodelling to the host tissue Soft tissue patches for hernia repair, vaginal slings and pelvic floor reconstruction US market = US$865M in 2007 Expanding market due to lifestyle changes

==> picture [720 x 78] intentionally omitted <==

Research collaboration with West Australian institution seeding mesenchymal stem cells onto ADAPT TEP bovine pericardium

==> picture [324 x 201] intentionally omitted <==

==> picture [720 x 78] intentionally omitted <==

Growth in Biologics

Change in demographics Technological (ageing advancements population)

Reduced Increasing hospitalisation obesity levels costs

“Because commercial soft tissue meshes are indicated for use in a wide variety of minimally invasive and open surgical procedures, rising procedure volumes will increase the size of the potential pool for commercial soft tissue devices.

Accordingly, unit sales will accelerate, thus driving revenue increases in the overall tissue market.”

Source: Millennium Research Group

==> picture [720 x 78] intentionally omitted <==

Commercialisation

==> picture [24 x 21] intentionally omitted <==

Discussions with US medical device companies

==> picture [20 x 18] intentionally omitted <==

1[st] tier company

==> picture [20 x 18] intentionally omitted <==

• 2[nd] tier company

==> picture [24 x 21] intentionally omitted <==

Targeting hernia repair and pelvic floor markets

==> picture [720 x 78] intentionally omitted <==

The Year Ahead…

==> picture [24 x 21] intentionally omitted <==

Completion of Cardiovascular Phase II Human Clinical Trial

==> picture [24 x 22] intentionally omitted <==

==> picture [24 x 21] intentionally omitted <==

Commencement of an Australian Human Clinical Trial in the Pelvic Floor / Hernia Global partnering for ADAPT TEP

==> picture [720 x 78] intentionally omitted <==

At a glance…

==> picture [704 x 306] intentionally omitted <==

----- Start of picture text -----

Group Cash
position
Fully Paid
@ 31/10/08
Ordinary 24 March
Shares 2004
$1.0 million
85.9 million
Group Average
Top 50
Cash Burn
Shareholders Market
(Sep QTR)
Capitalisation
75.8%
----- End of picture text -----

For all the latest news and updates visit: www.biomd.com.au